Prognostic Value of Programmed Cell Death 1 Ligand-1 in Patients With Bone and Soft Tissue Sarcomas: A Systemic and Comprehensive Meta-Analysis Based on 3,680 Patients

Background: Programmed cell death 1 ligand-1 (PD-L1) is an immune checkpoint molecule that acts to protect cancer cells from immune surveillance and is considered as a prognostic biomarker in several cancers, but the prognostic value of PD-L1 in bone and soft tissue sarcomas remains inconclusive. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Feng, Yu, Tao, Ma, Chengbin, Yuan, Hongmou, Zhang, Haifei, Zhang, Zhiyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280448/
https://www.ncbi.nlm.nih.gov/pubmed/32582532
http://dx.doi.org/10.3389/fonc.2020.00749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280448/
https://www.ncbi.nlm.nih.gov/pubmed/32582532
http://dx.doi.org/10.3389/fonc.2020.00749

Ejemplares similares